The combination of the two biomarkers in a multivariate discriminant model could provide better sensitivity and specificity compared with that obtained using AFP or hCG alone, thus demonstrating how the combined use of hCG and AFP can represent valid support in the diagnosis and follow-up of NGGCT neoplastic diseases. The gene discussed is AFP; the disease is neoplasm.